 Roy Morello
Concepts (222)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis Imperfecta | 13 | 2022 | 37 | 3.920 |
Why?
| | Collagen Type I | 6 | 2022 | 83 | 2.070 |
Why?
| | Extracellular Matrix Proteins | 10 | 2020 | 69 | 1.790 |
Why?
| | Bone and Bones | 9 | 2021 | 492 | 1.630 |
Why?
| | Molecular Chaperones | 9 | 2020 | 76 | 1.200 |
Why?
| | Autoantigens | 3 | 2017 | 47 | 1.030 |
Why?
| | Mutation | 12 | 2022 | 1331 | 1.020 |
Why?
| | Collagen | 7 | 2022 | 215 | 0.960 |
Why?
| | Endoplasmic Reticulum | 3 | 2017 | 99 | 0.900 |
Why?
| | Procollagen-Proline Dioxygenase | 3 | 2017 | 12 | 0.880 |
Why?
| | Ehlers-Danlos Syndrome | 2 | 2022 | 8 | 0.880 |
Why?
| | Disease Models, Animal | 6 | 2022 | 1483 | 0.830 |
Why?
| | Proteins | 7 | 2018 | 353 | 0.800 |
Why?
| | Mice | 23 | 2025 | 5899 | 0.760 |
Why?
| | Protein Processing, Post-Translational | 5 | 2020 | 152 | 0.760 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 97 | 0.690 |
Why?
| | Endocrinology | 1 | 2020 | 12 | 0.670 |
Why?
| | Gene Expression | 2 | 2021 | 618 | 0.670 |
Why?
| | Animals | 24 | 2025 | 13485 | 0.610 |
Why?
| | Osteocytes | 1 | 2021 | 219 | 0.590 |
Why?
| | Gene Targeting | 1 | 2018 | 29 | 0.580 |
Why?
| | Rare Diseases | 1 | 2018 | 47 | 0.570 |
Why?
| | Mice, Knockout | 11 | 2023 | 903 | 0.570 |
Why?
| | Bone Diseases | 1 | 2018 | 91 | 0.540 |
Why?
| | Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2016 | 7 | 0.500 |
Why?
| | Homeostasis | 3 | 2023 | 206 | 0.450 |
Why?
| | Energy Metabolism | 3 | 2025 | 315 | 0.430 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2010 | 146 | 0.400 |
Why?
| | Mice, Inbred C57BL | 11 | 2025 | 1888 | 0.400 |
Why?
| | Lung | 3 | 2022 | 479 | 0.360 |
Why?
| | Hydroxylation | 4 | 2017 | 64 | 0.340 |
Why?
| | Connective Tissue Diseases | 1 | 2010 | 18 | 0.330 |
Why?
| | Cells, Cultured | 4 | 2020 | 1583 | 0.320 |
Why?
| | Bone Development | 1 | 2010 | 68 | 0.310 |
Why?
| | Syndactyly | 1 | 2008 | 4 | 0.290 |
Why?
| | Extremities | 1 | 2008 | 31 | 0.290 |
Why?
| | Cartilage | 1 | 2008 | 47 | 0.290 |
Why?
| | DNA | 1 | 2010 | 544 | 0.260 |
Why?
| | Osteogenesis | 3 | 2020 | 368 | 0.260 |
Why?
| | Membrane Proteins | 2 | 2008 | 344 | 0.260 |
Why?
| | Extracellular Matrix | 2 | 2018 | 116 | 0.250 |
Why?
| | Humans | 22 | 2023 | 52441 | 0.240 |
Why?
| | Kidney Glomerulus | 2 | 2002 | 41 | 0.230 |
Why?
| | Housing, Animal | 1 | 2025 | 18 | 0.230 |
Why?
| | X-Ray Microtomography | 2 | 2022 | 79 | 0.230 |
Why?
| | Adipose Tissue, Brown | 1 | 2025 | 45 | 0.220 |
Why?
| | Temperature | 1 | 2025 | 166 | 0.220 |
Why?
| | Adipose Tissue | 1 | 2025 | 205 | 0.200 |
Why?
| | NAD | 1 | 2023 | 46 | 0.200 |
Why?
| | Relaxin | 1 | 2022 | 2 | 0.200 |
Why?
| | Chondrocytes | 3 | 2008 | 40 | 0.190 |
Why?
| | Nail-Patella Syndrome | 1 | 2002 | 1 | 0.190 |
Why?
| | Collagen Type V | 1 | 2022 | 4 | 0.190 |
Why?
| | Haploinsufficiency | 1 | 2022 | 16 | 0.190 |
Why?
| | Transcription, Genetic | 2 | 2003 | 375 | 0.180 |
Why?
| | Proteoglycans | 2 | 2014 | 86 | 0.180 |
Why?
| | Cyclophilins | 3 | 2016 | 9 | 0.170 |
Why?
| | Calcification, Physiologic | 2 | 2020 | 42 | 0.170 |
Why?
| | Insulin | 3 | 2022 | 485 | 0.160 |
Why?
| | Membrane Glycoproteins | 2 | 2014 | 239 | 0.160 |
Why?
| | Craniofacial Abnormalities | 1 | 2020 | 27 | 0.160 |
Why?
| | Mice, Transgenic | 3 | 2018 | 566 | 0.160 |
Why?
| | Cell Differentiation | 3 | 2008 | 667 | 0.160 |
Why?
| | Fractures, Bone | 1 | 2020 | 105 | 0.150 |
Why?
| | Male | 12 | 2022 | 26874 | 0.150 |
Why?
| | Transcriptome | 1 | 2021 | 357 | 0.150 |
Why?
| | Rabbits | 2 | 2018 | 370 | 0.150 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2018 | 6 | 0.150 |
Why?
| | Calcium, Dietary | 1 | 2018 | 12 | 0.150 |
Why?
| | Osteitis Deformans | 1 | 2018 | 6 | 0.150 |
Why?
| | Chondrogenesis | 2 | 2008 | 12 | 0.140 |
Why?
| | Gene-Environment Interaction | 1 | 2018 | 41 | 0.140 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2018 | 75 | 0.140 |
Why?
| | Fibroblasts | 3 | 2010 | 357 | 0.140 |
Why?
| | Metabolic Networks and Pathways | 1 | 2018 | 89 | 0.140 |
Why?
| | Osteochondrodysplasias | 2 | 2008 | 14 | 0.130 |
Why?
| | Female | 8 | 2025 | 28277 | 0.130 |
Why?
| | Molecular Targeted Therapy | 1 | 2018 | 135 | 0.130 |
Why?
| | Testis | 2 | 2022 | 74 | 0.130 |
Why?
| | Pelvis | 1 | 2017 | 65 | 0.130 |
Why?
| | Cell Line | 3 | 2016 | 1020 | 0.130 |
Why?
| | Calcium | 1 | 2018 | 396 | 0.130 |
Why?
| | Mice, Mutant Strains | 2 | 2014 | 72 | 0.130 |
Why?
| | Lysine | 1 | 2017 | 90 | 0.120 |
Why?
| | Virulence | 1 | 2016 | 160 | 0.120 |
Why?
| | Virulence Factors | 1 | 2016 | 78 | 0.120 |
Why?
| | DNA Mutational Analysis | 4 | 2011 | 179 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 525 | 0.110 |
Why?
| | Osteomyelitis | 1 | 2016 | 125 | 0.110 |
Why?
| | Molecular Sequence Data | 4 | 2011 | 778 | 0.110 |
Why?
| | Organ Size | 1 | 2014 | 226 | 0.100 |
Why?
| | Polymerase Chain Reaction | 3 | 2010 | 458 | 0.100 |
Why?
| | Staphylococcus aureus | 1 | 2016 | 312 | 0.100 |
Why?
| | Bacterial Proteins | 1 | 2016 | 347 | 0.100 |
Why?
| | In Situ Hybridization | 2 | 2010 | 69 | 0.090 |
Why?
| | Rats | 1 | 2018 | 3228 | 0.090 |
Why?
| | Serpins | 1 | 2011 | 4 | 0.090 |
Why?
| | Skin | 2 | 2017 | 416 | 0.090 |
Why?
| | Cell Proliferation | 3 | 2010 | 1013 | 0.090 |
Why?
| | Nerve Growth Factors | 1 | 2011 | 26 | 0.090 |
Why?
| | Eye Proteins | 1 | 2011 | 16 | 0.090 |
Why?
| | Amino Acid Sequence | 3 | 2010 | 576 | 0.090 |
Why?
| | Transcription Factors | 3 | 2003 | 570 | 0.090 |
Why?
| | Cell Respiration | 1 | 2010 | 42 | 0.080 |
Why?
| | Connective Tissue | 1 | 2010 | 9 | 0.080 |
Why?
| | Proline | 1 | 2010 | 31 | 0.080 |
Why?
| | Osteoporosis | 2 | 2010 | 157 | 0.080 |
Why?
| | Ascorbic Acid | 1 | 2010 | 25 | 0.080 |
Why?
| | Mitochondrial Proteins | 1 | 2010 | 91 | 0.080 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 110 | 0.080 |
Why?
| | Blotting, Northern | 1 | 2008 | 107 | 0.070 |
Why?
| | In Situ Nick-End Labeling | 1 | 2008 | 54 | 0.070 |
Why?
| | Tandem Mass Spectrometry | 1 | 2010 | 255 | 0.070 |
Why?
| | GATA Transcription Factors | 1 | 2008 | 4 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2003 | 1004 | 0.070 |
Why?
| | RNA, Messenger | 2 | 2010 | 1134 | 0.070 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 57 | 0.070 |
Why?
| | Fibrillar Collagens | 1 | 2006 | 2 | 0.060 |
Why?
| | Mitochondria | 1 | 2010 | 420 | 0.060 |
Why?
| | Immunohistochemistry | 3 | 2020 | 977 | 0.060 |
Why?
| | Bone Diseases, Metabolic | 1 | 2006 | 80 | 0.060 |
Why?
| | LIM-Homeodomain Proteins | 2 | 2002 | 3 | 0.060 |
Why?
| | Basement Membrane | 2 | 2002 | 19 | 0.060 |
Why?
| | Osteoclasts | 2 | 2020 | 423 | 0.060 |
Why?
| | Kidney | 1 | 2010 | 716 | 0.060 |
Why?
| | Thermogenesis | 1 | 2025 | 31 | 0.060 |
Why?
| | Homeodomain Proteins | 2 | 2002 | 80 | 0.060 |
Why?
| | Models, Biological | 2 | 2010 | 735 | 0.050 |
Why?
| | Collagen Type X | 1 | 2003 | 3 | 0.050 |
Why?
| | Apoptosis | 1 | 2008 | 1120 | 0.050 |
Why?
| | Receptors, Peptide | 1 | 2022 | 7 | 0.050 |
Why?
| | Gonadal Steroid Hormones | 1 | 2022 | 41 | 0.050 |
Why?
| | Multiple Myeloma | 1 | 2017 | 3013 | 0.050 |
Why?
| | Cell Surface Extensions | 1 | 2002 | 2 | 0.050 |
Why?
| | Capillary Permeability | 1 | 2002 | 29 | 0.050 |
Why?
| | Genetic Diseases, Inborn | 1 | 2002 | 25 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2023 | 327 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2002 | 127 | 0.050 |
Why?
| | Adult | 5 | 2022 | 14205 | 0.050 |
Why?
| | Zebrafish | 1 | 2002 | 61 | 0.050 |
Why?
| | Nephrotic Syndrome | 1 | 2002 | 34 | 0.050 |
Why?
| | Models, Animal | 1 | 2002 | 230 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2003 | 328 | 0.040 |
Why?
| | Epithelial Cells | 1 | 2002 | 217 | 0.040 |
Why?
| | Osteoblasts | 2 | 2016 | 478 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2002 | 263 | 0.040 |
Why?
| | Periodontal Ligament | 1 | 2020 | 3 | 0.040 |
Why?
| | Time Factors | 1 | 2006 | 2987 | 0.040 |
Why?
| | Cytokines | 1 | 2023 | 622 | 0.040 |
Why?
| | Skull | 1 | 2020 | 77 | 0.040 |
Why?
| | Pregnancy | 1 | 2025 | 2642 | 0.030 |
Why?
| | Infant, Newborn | 3 | 2011 | 2871 | 0.030 |
Why?
| | Dentin | 1 | 2017 | 7 | 0.030 |
Why?
| | Cross-Linking Reagents | 1 | 2017 | 42 | 0.030 |
Why?
| | Phenotype | 1 | 2020 | 792 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2017 | 92 | 0.030 |
Why?
| | Cornea | 1 | 2017 | 53 | 0.030 |
Why?
| | Operon | 1 | 2016 | 24 | 0.030 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 2 | 2008 | 45 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 150 | 0.030 |
Why?
| | Aorta | 1 | 2017 | 170 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 245 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 294 | 0.030 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2016 | 176 | 0.030 |
Why?
| | Skeleton | 1 | 2014 | 1 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 22 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2014 | 28 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 60 | 0.030 |
Why?
| | Proteomics | 1 | 2016 | 332 | 0.030 |
Why?
| | Staphylococcal Infections | 1 | 2016 | 270 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 1140 | 0.020 |
Why?
| | Pedigree | 1 | 2011 | 126 | 0.020 |
Why?
| | Spermatocytes | 1 | 2010 | 3 | 0.020 |
Why?
| | Spermatids | 1 | 2010 | 4 | 0.020 |
Why?
| | Sertoli Cells | 1 | 2010 | 4 | 0.020 |
Why?
| | Leydig Cells | 1 | 2010 | 9 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 632 | 0.020 |
Why?
| | RNA Interference | 1 | 2010 | 183 | 0.020 |
Why?
| | HeLa Cells | 1 | 2010 | 243 | 0.020 |
Why?
| | Transfection | 1 | 2010 | 365 | 0.020 |
Why?
| | Flavonoids | 1 | 2010 | 55 | 0.020 |
Why?
| | Stilbenes | 1 | 2010 | 58 | 0.020 |
Why?
| | Phylogeny | 1 | 2010 | 229 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2010 | 193 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2010 | 234 | 0.020 |
Why?
| | Consanguinity | 1 | 2008 | 18 | 0.020 |
Why?
| | Cyclic AMP | 1 | 2009 | 90 | 0.020 |
Why?
| | Growth Plate | 1 | 2008 | 10 | 0.020 |
Why?
| | Antioxidants | 1 | 2010 | 255 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2011 | 1223 | 0.020 |
Why?
| | Prenatal Diagnosis | 1 | 2008 | 97 | 0.020 |
Why?
| | Loss of Heterozygosity | 1 | 2008 | 78 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2008 | 127 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 580 | 0.020 |
Why?
| | Plant Extracts | 1 | 2010 | 199 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 161 | 0.020 |
Why?
| | Genes, Recessive | 1 | 2006 | 16 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2008 | 150 | 0.020 |
Why?
| | Bone Density | 1 | 2009 | 396 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 1365 | 0.010 |
Why?
| | Radiography | 1 | 2006 | 469 | 0.010 |
Why?
| | Ultrasonography, Prenatal | 1 | 2006 | 180 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2009 | 1429 | 0.010 |
Why?
| | Humerus | 1 | 2003 | 16 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 73 | 0.010 |
Why?
| | Hypertrophy | 1 | 2003 | 53 | 0.010 |
Why?
| | Infant | 1 | 2011 | 3709 | 0.010 |
Why?
| | Aged | 1 | 2017 | 10242 | 0.010 |
Why?
| | Femur | 1 | 2003 | 132 | 0.010 |
Why?
| | Child, Preschool | 1 | 2011 | 4046 | 0.010 |
Why?
| | Binding Sites | 1 | 2003 | 379 | 0.010 |
Why?
| | Collagen Type IV | 1 | 2002 | 11 | 0.010 |
Why?
| | Laminin | 1 | 2002 | 20 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2002 | 47 | 0.010 |
Why?
| | Glomerular Filtration Rate | 1 | 2002 | 126 | 0.010 |
Why?
| | Blood Proteins | 1 | 2002 | 84 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 13133 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2002 | 304 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2003 | 465 | 0.010 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2002 | 202 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 6713 | 0.010 |
Why?
| | Child | 1 | 2011 | 7194 | 0.010 |
Why?
|
|
Morello's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|